Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation-Reference-Cited by-同舟云学术

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation

Published:2015-01 Issue:1 Volume:21 Page:79-86
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Farmakiotis Dimitrios,Kyvernitakis A.,Tarrand J.J.,Kontoyiannis D.P.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America;Pappas;Clin Infect Dis,2009

2. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy;Antoniadou;Medicine,2003

3. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy;Hachem;Cancer,2008

4. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001–2007): stable incidence but changing epidemiology of a still frequently lethal infection;Sipsas;Cancer,2009

5. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated MIC;Alexander;Clin Infect Dis,2013

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List;Medical Mycology;2024-06

2. Clinical impact of the combination of rapid species identification and antifungal stewardship intervention in adults with candidemia;Journal of Microbiology, Immunology and Infection;2023-12

3. Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models;BMC Infectious Diseases;2023-04-18

4. The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study;Frontiers in Pharmacology;2023-03-02

5. Epidemiology, Antifungal Susceptibility, and Risk Factors of Invasive Candidiasis in a Tertiary Hospital During a Four-Year Period;Jundishapur Journal of Microbiology;2023-01-20